
Labs in Court: A Focus on Individual Accountability
Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters

Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing

Examining DOJ and OIG investigations of labs and their owners: Recent cases show continued focus on the usual enforcement targets.